CHIP-Carrying Multiple Myeloma Correlates With More Aggressive Disease
Clonal hematopoiesis may be associated with the early development of toxic events in patients with newly diagnosed multiple myeloma.
Expanding and Advancing the Future of Renal Cell Carcinoma Treatment
Eric Jonasch, MD, believes that the Kidney Cancer Research Consortium may broaden their reach to provide care to many different groups of patients.
CHMP Recommends EU Approval for Durvalumab in Limited-Stage SCLC
Support for the recommendation is based on phase 3 ADRIATIC trial results showing a 27% reduction in the risk of death with durvalumab vs placebo.
Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology
Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.
Integrative Oncology Approaches to Managing Gastrointestinal Cancer
Options like acupuncture or cannabis use may be viable to help manage symptoms related to gastrointestinal cancer treatment.
Encorafenib Combo Improves PFS in Metastatic Colorectal Cancer
Full progression-free survival results for patients with BRAF V600E mCRC from the phase 3 BREAKWATER trial will be presented at an upcoming medical conference.
